Baxter Pharmaceuticals India Pvt Ltd — Ahmedabad
USFDA inspection record for FEI 3004610460, Ahmedabad, India.
OAI
Latest classification
2
Inspections on record
2
Form 483 observations on record
History (newest first)
Inspections
27 Jan 2023
OAI — Official action indicated
Drug Quality Assurance · Drugs · FY2023
Form 483: 2 observations
- Written procedures followed (21 CFR 211.186(a))
- In-Process and Laboratory Control Results (21 CFR 211.188(b)(5))
Source: FDA Data Dashboard ↗
17 May 2022
VAI — Voluntary action indicated
Drug Quality Assurance · Drugs · FY2022
Source: FDA Data Dashboard ↗
FDA compliance actions
| Date | Action | Product type |
|---|---|---|
| 25 Jul 2023 | Warning Letter | Drugs |
📎 Cite this data: Source: PharmaRoz, FDA inspection record for FEI 3004610460, updated 12 Nov 2026